Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · IEX Real-Time Price · USD
2.800
-0.130 (-4.44%)
At close: Jul 19, 2024, 4:00 PM
2.790
-0.010 (-0.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Evaxion Biotech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Evaxion Biotech stock have an average target of 11, with a low estimate of 8.00 and a high estimate of 14. The average target predicts an increase of 292.86% from the current stock price of 2.80.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 4, 2024.
Analyst Ratings
The average analyst rating for EVAX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +400.00% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +400.00% | Apr 3, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +185.71% | Apr 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +400.00% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +400.00% | Feb 12, 2024 |
Financial Forecast
Revenue This Year
167.28K
from 73.00K
Increased by 129.15%
Revenue Next Year
128.01K
from 167.28K
Decreased by -23.48%
EPS This Year
-1.79
from -8.10
EPS Next Year
-1.84
from -1.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 239,400 | 263,550 | 128.1M | 30.6M | 95.6M |
| Avg | 167,280 | 128,010 | 64.8M | 29.7M | 92.9M |
| Low | 98,000 | n/a | 4.9M | 28.5M | 89.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 227.9% | 57.6% | 99,946.9% | -52.8% | 221.8% |
| Avg | 129.2% | -23.5% | 50,486.7% | -54.1% | 212.6% |
| Low | 34.2% | - | 3,727.8% | -55.9% | 200.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.84 | -0.28 | 4.20 | - | 3.89 |
| Avg | -1.79 | -1.84 | 4.08 | - | 3.77 |
| Low | -1.71 | -3.27 | 3.92 | - | 3.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.